ARCHIVES

FDA Likely To Change Procedures For Patient Interaction, Official Says

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

New Treatment Approaches Valuable For Cancer Pain, Quality Of Life

September 27, 2002

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

April 27, 2012

In Brief: Obey Fears Hangup On Abortion Funding will Kill Labor-Hew Appropriations Bill

July 6, 1979

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

Phase II Elotuzumab Study Demonstrates 33 Months PFS

July 26, 2013